Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

Naoto Fujiwara; Amit G. Singal; Yujin Hoshida

doi:10.1002/hep.30813

Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

Naoto Fujiwara, Amit G. Singal, Yujin Hoshida

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2216-2217
Number of pages	2
Journal	Hepatology
Volume	70
Issue number	6
DOIs	https://doi.org/10.1002/hep.30813
State	Published - Dec 1 2019

ASJC Scopus subject areas

Hepatology

Access to Document

10.1002/hep.30813

Cite this

@article{342279958f0d4ff4b97eb49ccd485e14,

title = "Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma",

author = "Naoto Fujiwara and Singal, {Amit G.} and Yujin Hoshida",

year = "2019",

month = dec,

day = "1",

doi = "10.1002/hep.30813",

language = "English (US)",

volume = "70",

pages = "2216--2217",

journal = "Hepatology",

issn = "0270-9139",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

AU - Fujiwara, Naoto

AU - Singal, Amit G.

AU - Hoshida, Yujin

PY - 2019/12/1

Y1 - 2019/12/1

UR - http://www.scopus.com/inward/record.url?scp=85070913929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070913929&partnerID=8YFLogxK

U2 - 10.1002/hep.30813

DO - 10.1002/hep.30813

M3 - Comment/debate

C2 - 31206214

AN - SCOPUS:85070913929

SN - 0270-9139

VL - 70

SP - 2216

EP - 2217

JO - Hepatology

JF - Hepatology

IS - 6

ER -

Dose and Duration of Aspirin Use to Reduce Incident Hepatocellular Carcinoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this